SI-Bone (NASDAQ:SIBN) announced its earnings results on Monday. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.36) by ($0.10), Fidelity Earnings reports. The firm had revenue of $16.18 million during the quarter. SI-Bone had a negative net margin of 46.59% and a negative return on equity of 84.84%.

Shares of SIBN stock traded down $0.74 on Wednesday, hitting $17.69. The stock had a trading volume of 248,800 shares, compared to its average volume of 122,092. The firm has a market capitalization of $454.67 million and a price-to-earnings ratio of -24.92. The stock’s 50 day moving average is $17.21 and its 200-day moving average is $18.00. The company has a debt-to-equity ratio of 0.50, a quick ratio of 11.55 and a current ratio of 12.00. SI-Bone has a 52-week low of $14.08 and a 52-week high of $23.03.

In other SI-Bone news, CEO Jeffrey W. Dunn sold 7,250 shares of the stock in a transaction on Friday, October 18th. The shares were sold at an average price of $16.03, for a total transaction of $116,217.50. Also, insider Anthony J. Recupero sold 1,400 shares of the stock in a transaction on Monday, November 4th. The shares were sold at an average price of $19.45, for a total transaction of $27,230.00. Insiders sold 383,524 shares of company stock valued at $7,185,937 over the last 90 days. Insiders own 38.80% of the company’s stock.

Separately, ValuEngine downgraded shares of SI-Bone from a “buy” rating to a “hold” rating in a research note on Monday, November 4th.

About SI-Bone

SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Further Reading: Death Cross

Earnings History for SI-Bone (NASDAQ:SIBN)

Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with's FREE daily email newsletter.